Dissociation of DNA from Histone by Reaction of Anti-cancer Drug cis-Diamminedichloroplatinum(II) with DNA-Histone Complexes Used as Cellular Model

DOI Web Site Web Site 被引用文献1件 参考文献22件
  • Koyama Yuhki
    Division of Analytical Chemistry of Medicines, Showa Pharmaceutical University
  • Kikuchi Sachie
    Division of Analytical Chemistry of Medicines, Showa Pharmaceutical University
  • Nakagawa Sayaka
    Division of Analytical Chemistry of Medicines, Showa Pharmaceutical University
  • Kobayashi Shigeki
    Division of Analytical Chemistry of Medicines, Showa Pharmaceutical University

書誌事項

タイトル別名
  • Dissociation of DNA from histone by reaction of anti cancer drug cis diamminedichloroplatinum 2 with DNA histone complexes used as cellular model

この論文をさがす

説明

Although both cis-diamminedichloroplatinum(II) (cisplatin or cis-DDP) and trans-diamminedichloroplatinum(II) bind to DNA, only cis-DDP is widely used as a chemotherapeutic agent; the stereoisomer trans-DDP is inactive. DNA, generally, is wound around the histone core in the nucleus of living cells and forms the nucleosome structure. To understand the essentially different anticancer activities of cis-DDP and trans-DDP, it is necessary to investigate the interaction of cis-DDP (or trans-DDP) with DNA around the histone in the nucleosome. Here, we used φX174DNA–histoneLNCaP complexes prepared by the reaction of φX174DNA with histoneLNCaP extracted from LNCaP cells. We first show that the ability of cis-DDP to dissociate the DNA from φX174DNA–histoneLNCaP, as a nucleosome model, is much stronger than that of trans-DDP. As a result of the action of cis-DDP, the DNA in the nucleosome is rendered naked, and the naked DNA is vulnerable to cis-DDP (or other drugs). This study describes a new model showing that the difference in the activities of cis-DDP and trans-DDP is related to the difference in their abilities to dissociate the DNA from the nucleosome.

収録刊行物

被引用文献 (1)*注記

もっと見る

参考文献 (22)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ